Digging Deep

Defense Metals in the Media

February 16, 2024

Our 2024 Predictions, Part 2

January 11, 2024

Our 2024 Predictions, Part 1

January 02, 2023

Can Gold Hit $3,000 in 2024?

29 December, 2023

Will Bitcoin ETFs Kill Gold?

November 21, 2023

What's Next for Gold?

06 June, 2023

Platinum and Palladium

February 2022

Transition to Production

June 15, 2021

Silver Suppression?!

February 02, 2021

Gold: Year in Review 2020, and 2021 Outlook

January 04, 2021

Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More

AbraPlata: CMR's full analysis of an Argentina focussed gold and silver junior

May 2020

The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More

$SOFI - SoFi: Leading In A Crisis.

March 27, 2023 / seekingalpha.com

SoFi launched a $2M solution to the FDIC insurance limits to garner more deposits during this banking crisis. Read why SOFI stock remains an incredible bargain.Read full newsRead More

$VTRS - Viatris: The Value And The Value Trap.

March 26, 2023 / seekingalpha.com

To say Viatris has been a sore disappointment since its spin-off, would be a massive understatement.Read full newsRead More

$AMZN - Is Amazon Poised For A Q1 Turnaround? 4 Signs To Watch.

March 26, 2023 / seekingalpha.com

Amazon investors must wonder: when will results finally turn the corner? Persistent headwinds dog the company.Read full newsRead More

$SP500 $NDX $SPX - Dow Theory Is Posing A Big Question That You Need To Answer.

March 26, 2023 / seekingalpha.com

We explore two principles of Dow Theory that analyze, in very different ways, the relationship of certain macro-economic fundamental trends with trends in price action.Read full newsRead More

2 Great Dividends To Buy And Hold For Decades.

March 26, 2023 / seekingalpha.com

Investors should measure holding periods in years, not days or weeks. Read more to see our two picks, WPC and DMB, to hold for the long term.Read full newsRead More

$LULU - Lululemon: Shares On Discount Ahead Of Earnings, Monitoring Technical Support.

March 26, 2023 / seekingalpha.com

The growth style has rallied to fresh multi-month highs versus value. Lower interest rates are a boon to longer-duration plays tied to the consumer and tech.Read full newsRead More

$T - AT&T: Are Your Dividends Safe?.

March 26, 2023 / seekingalpha.com

There are no reasons to believe that AT&T will cut its dividends to significantly decrease its debt anytime soon. Read more to see why T stock is a Buy.Read full newsRead More

$GCCRF - Gram Car Carriers: I Expect The Current 5% Yield To More Than Double This Year.

March 26, 2023 / seekingalpha.com

Gram Car Carriers operates and manages RoRo ships focusing on the transportation of cars and vehicles. See why I'm bullish on GCCRF stock.Read full newsRead More

$AMH - American Homes 4 Rent: A Great Catalyst, But At A Not-So-Great Price.

March 26, 2023 / seekingalpha.com

American Homes 4 Rent has demonstrated itself to be a great firm with an amazing ability to grow over time. Click here to see our take on AMH stock.Read full newsRead More

$RNSDF - Renault: Ampere IPO Is A Key Catalyst.

March 26, 2023 / seekingalpha.com

Renault will become a holding company and Amp??re will be its jewel. Click here to read our analysis and why we think RNSDF stock is a buy.Read full newsRead More

Gold: Party Is Not Over Just Yet.

March 26, 2023 / seekingalpha.com

Federal Reserve's decision at latest meeting to leave interest rates unchanged and to continue its monthly asset purchases was widely anticipated. Click here to read my thoughts.Read full newsRead More

$PEP - PepsiCo: Great Long-Term Play, Short-Term Tactical Concerns.

March 26, 2023 / seekingalpha.com

PepsiCo has seen solid growth in 2022, albeit driven by pricing rather than volumes. Click here to read my analysis of PEP stock.Read full newsRead More

$NMR - Nomura Shows Resilience In Investment Banking.

March 26, 2023 / seekingalpha.com

Nomura is better positioned than most publicly listed shops, its business mix isn't going to be a severe issue. Check out my recommendation on NMR stock.Read full newsRead More

$KBH $NVR - KB Home Vs. NVR: Battle Of The Builders.

March 26, 2023 / seekingalpha.com

Insatiable demands meet unaffordable financing. Global fallout wreaked havoc on the share price of KB Home and NVR. Click here to see our take on KBH vs NVR.Read full newsRead More

$BFI - Burgerfi International, Inc. (BFI) Q4 2022 Earnings Call Transcript.

March 26, 2023 / seekingalpha.com

Burgerfi International, Inc. (NASDAQ:NASDAQ:BFI) Q4 2022 Earnings Conference Call March 22, 2023 8:30 AM ETCompany ParticipantsIan Baines - CEOMichael Rabinovitch - SVP, CFO & Principal...Read full newsRead More

$M - Macy's: Headwinds Blowing Too Hard.

March 26, 2023 / seekingalpha.com

Industry is hyper-competitive, and the pandemic accelerated Macy's loss of market share. Click here to see our take on M stock.Read full newsRead More

$AAPL - Apple's Rally Is Likely Sustainable Fueled By Forex And Innovation.

March 26, 2023 / seekingalpha.com

Apple's potential forex headwinds are likely going to become a forex tailwind as the US dollar's strength declines. See why I rate AAPL stock a buy.Read full newsRead More

$SKY - Skyline Champion: Capitalizing On The Unaffordable Housing Crisis.

March 26, 2023 / seekingalpha.com

Skyline Champion is a leading player in the factory-built housing market. Click here to read our analysis and why we think SKY stock is a buy.Read full newsRead More

$RC - Here Are 4 REITs To Watch In 2023 - My Favorite Is Ready Capital.

March 26, 2023 / seekingalpha.com

I review 4 mREITs that I believe offer a buying opportunity for income-oriented investors with a long-term horizon. Find out why my favorite is Ready Capital.Read full newsRead More

$ACRV - Acrivon: Precision-Testing Your Trial Patients Before Enrolment.

March 26, 2023 / seekingalpha.com

Acrivon has a platform that tests trial patients for sensitivity to a tested drug before enrolling them. See why I'm neutral on ACRV stock.Read full newsRead More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok